Article info
PDFReview
Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54
- Correspondence to Professor Robert F Storey, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; r.f.storey{at}sheffield.ac.uk
Citation
Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54
Publication history
- Received September 23, 2015
- Revised January 7, 2016
- Accepted January 8, 2016
- First published February 8, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
- latest version (18 January 2021).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/